Hande Topel

Hande Topel

Auto-generated profile, based on publicly available information

Hande Topel

Department for Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in New Biotechnology
Verified
Journal Article
Closed access
COCigdem Ozen
Cigdem Ozen
GYGokhan YILDIZ
Gokhan YILDIZ
ADAlper Tunga Dagcan
Alper Tunga Dagcan
DCDilek Cevik
Dilek Cevik
AOAysegul Ors
Aysegul Ors
MOMehmet Ozturk
Mehmet Ozturk

11 July 2020 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
HTHande Topel
Hande Topel
EBEzgi Bagirsakci
Ezgi Bagirsakci
DCDehan Comez
Dehan Comez
GBGulsun Bagci
Gulsun Bagci
GAGülçin Çakan Akdoğan
Gülçin Çakan Akdoğan
NANese Atabey
Nese Atabey
Background: Epithelial-to-mesenchymal transition (EMT) and mesenchymal-to-epithelial transition (MET) are both reversible processes, and regulation of phenotypical transition is very important for progression of several cancers including hepatocellular carcinoma (HCC). Recently, it is defined that cancer cells can attain a hybrid epithelial/mesenchymal (hybrid E/M) phenotype. Cells with hybrid E/M phenotype comprise mixed epithelial and mesenchymal properties, they can be more resistant to therapeutics and also more capable of initiating metastatic lesions. However, the mechanisms regulating hybrid E/M in HCC are not well described yet. In this study, we investigated the role of the potential crosstalk between lncRNA HOTAIR and c-Met receptor tyrosine kinase, which are two essential regulators of EMT and MET, in acquiring of hybrid E/M phenotype in HCC. Methods: Expression of c-Met and lncRNA HOTAIR were defined in HCC cell lines and patient tissues through HCC progression. lncRNA HOTAIR was overexpressed in SNU-449 cells and its effects on c-Met signaling were analyzed. c-Met was overexpressed in SNU-398 cells and its effect on HOTAIR expression was analyzed. Biological significance of HOTAIR/c-Met interplay was defined in means of adhesion, proliferation, motility behavior, invasion, spheroid formation and metastatic ability. Effect of ectopic lncRNA HOTAIR expression on phenotype was defined with investigation of molecular epithelial and mesenchymal traits. Results: In vitro and in vivo experiments verified the pivotal role of lncRNA HOTAIR in acquisition of hybrid E/M phenotype through modulating expression and activation of c-Met and its membrane co-localizing partner Caveolin-1, and membrane organization to cope with the rate limiting steps of metastasis such as survival in adhesion independent microenvironment, escaping from anoikis and resisting to fluidic shear stress (FSS) in HCC. Conclusions: Our work provides the first evidence suggesting a role for lncRNA HOTAIR in the modulation of c-Met to promote hybrid E/M phenotype. The balance between lncRNA HOTAIR and c-Met might be critical for cell fate decision and metastatic potential of HCC cells.

31 January 2020 in Nature Communications
Verified
Journal Article
Open access
MPMarta Pradas-Juni
Marta Pradas-Juni
NHNils R. Hansmeier
Nils R. Hansmeier
JLJenny C. Link
Jenny C. Link
ESElena Schmidt
Elena Schmidt
BLBjørk Ditlev Larsen
Bjørk Ditlev Larsen
JKJan-Wilhelm Kornfeld
Jan-Wilhelm Kornfeld
Obesity and type 2 diabetes mellitus are global emergencies and long noncoding RNAs (lncRNAs) are regulatory transcripts with elusive functions in metabolism. Here we show that a high fraction of lncRNAs, but not protein-coding mRNAs, are repressed during diet-induced obesity (DIO) and refeeding, whilst nutrient deprivation induced lncRNAs in mouse liver. Similarly, lncRNAs are lost in diabetic humans. LncRNA promoter analyses, global cistrome and gain-of-function analyses confirm that increased MAFG signaling during DIO curbs lncRNA expression. Silencing Mafg in mouse hepatocytes and obese mice elicits a fasting-like gene expression profile, improves glucose metabolism, de-represses lncRNAs and impairs mammalian target of rapamycin (mTOR) activation. We find that obesity-repressed LincIRS2 is controlled by MAFG and observe that genetic and RNAi-mediated LincIRS2 loss causes elevated blood glucose, insulin resistance and aberrant glucose output in lean mice. Taken together, we identify a MAFG-lncRNA axis controlling hepatic glucose metabolism in health and metabolic disease.

29 April 2024 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
SKSajjad Khani
Sajjad Khani
HTHande Topel
Hande Topel
RKRonja Kardinal
Ronja Kardinal
ATAna Rita Tavanez
Ana Rita Tavanez
AJAjeetha Josephrajan
Ajeetha Josephrajan
JKJan-Wilhelm Kornfeld
Jan-Wilhelm Kornfeld
Promoting brown adipose tissue (BAT) activity innovatively targets obesity and metabolic disease. While thermogenic activation of BAT is well understood, the rheostatic regulation of BAT to avoid excessive energy dissipation remains ill-defined. Here, we demonstrate that adenylyl cyclase 3 (AC3) is key for BAT function. We identified a cold-inducible promoter that generates a 5′ truncated AC3 mRNA isoform (Adcy3-at), whose expression is driven by a cold-induced, truncated isoform of PPARGC1A (PPARGC1A-AT). Male mice lacking Adcy3-at display increased energy expenditure and are resistant to obesity and ensuing metabolic imbalances. Mouse and human AC3-AT are retained in the endoplasmic reticulum, unable to translocate to the plasma membrane and lack enzymatic activity. AC3-AT interacts with AC3 and sequesters it in the endoplasmic reticulum, reducing the pool of adenylyl cyclases available for G-protein-mediated cAMP synthesis. Thus, AC3-AT acts as a cold-induced rheostat in BAT, limiting adverse consequences of cAMP activity during chronic BAT activation.

1 August 2015 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
AGAysim Gunes
Aysim Gunes
EIEvin Iscan
Evin Iscan
HTHande Topel
Hande Topel
SASanem Tercan Avci
Sanem Tercan Avci
MGMukaddes Gumustekin
Mukaddes Gumustekin
NANese Atabey
Nese Atabey

22 October 2018 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
PKPeyda Korhan
Peyda Korhan
YYYeliz Yılmaz
Yeliz Yılmaz
EBEzgi Bağırsakçı
Ezgi Bağırsakçı
AGAyşim Güneş
Ayşim Güneş
HTHande Topel
Hande Topel
NANese Atabey
Nese Atabey
Hepatocellular carcinoma (HCC) is a major health problem worldwide and most cases are incurable because of late presentation. It is the most common primary neoplasm of the liver and often arises in the context of a chronic liver disease that impairs coagulation. Portal vein thrombosis (PVT) is a common complication of HCC that is associated with a poor prognosis. Heparin derivatives are widely used in the management of venous thromboembolism (VTE). Among them low molecular weight heparin (LMWH) favorably influences the survival in patients with advanced cancer, including HCC. Due to their pleiotropic function, heparins affect tumorigenesis in many ways and may promote or hamper tumorigenic transformation depending on the cancer type and cancer stage along with their structural properties and concentration. Thus, their application as an antithrombotic along with the conventional therapy regime should be carefully planned to develop the best management strategies. In this review, we first will briefly review clinical applications of heparin derivatives in the management of cancer with a particular focus on HCC. We then summarize the state of knowledge whereby heparin can crosstalk with molecules playing a role in hepatocarcinogenesis. Lastly, we highlight new experimental and clinical research conducted with the aim of moving towards personalized therapy in cancer patients at risk of thromboembolism.